High EGR1 expression has been found in a variety of cancers such as gastric, colorectal, hepatocellular, and cervical cancer and has been associated with poorer prognostic outcomes such as distant metastasis and poor survival [7–10]. This evidence concerns the gene EGR1 and cancer.